BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 8552208)

  • 1. Comparison between serum levels of carcinoembryonic antigen, sialic acid and phosphohexose isomerase in lung cancer.
    Patel PS; Raval GN; Rawal RM; Patel GH; Balar DB; Shah PM; Patel DD
    Neoplasma; 1995; 42(5):271-4. PubMed ID: 8552208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Five tumor markers in lung cancer: significance of total and "lipid"-bound sialic acid.
    Kakari S; Stringou E; Toumbis M; Ferderigos AS; Poulaki E; Chondros K; Dema A; Kotsovoulou V; Pavlidis N
    Anticancer Res; 1991; 11(6):2107-10. PubMed ID: 1663720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum sialic acid (TSA/LSA) and carcinoembryonic antigen (CEA) levels in cancer patients undergoing radiotherapy.
    Stringou E; Chondros K; Kouvaris J; Kakari S; Papavassiliou K
    Anticancer Res; 1992; 12(1):251-5. PubMed ID: 1567173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative study of serum lipid-bound sialic acid and carcinoembryonic antigen in patients with lung cancer].
    Zhu X
    Zhonghua Jie He He Hu Xi Za Zhi; 1990 Feb; 13(1):25-7, 61. PubMed ID: 2165867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Serum lipid-bound sialic acid as a marker in lung cancer patients].
    Iwahashi N
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Dec; 28(12):1599-607. PubMed ID: 2077205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of serum CEA, PHI, and TPA as tumor markers in breast cancer patients.
    Paulick R; Caffier H; Paulick M
    Cancer Detect Prev; 1987; 10(3-4):197-203. PubMed ID: 3568016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple markers for lung cancer diagnosis: validation of models for advanced lung cancer.
    Gail MH; Muenz L; McIntire KR; Radovich B; Braunstein G; Brown PR; Deftos L; Dnistrian A; Dunsmore M; Elashoff R
    J Natl Cancer Inst; 1986 May; 76(5):805-16. PubMed ID: 2422426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum total sialic acid and regan isoenzyme levels in patients with lung cancer.
    Patel PS; Baxi BR; Desai SS; Balar DB
    Indian J Pathol Microbiol; 1990 Apr; 33(2):124-8. PubMed ID: 2391142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of histologic type and smoking status on interpretation of serum carcinoembryonic antigen value in non-small cell lung carcinoma.
    Okada M; Nishio W; Sakamoto T; Uchino K; Yuki T; Nakagawa A; Tsubota N
    Ann Thorac Surg; 2004 Sep; 78(3):1004-9; discussion 1009-10. PubMed ID: 15337038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing benefits of combining biochemical and immunological markers in patients with lung carcinoma.
    Patel PS; Raval GN; Rawal RR; Patel GH; Balar DB; Shah PM; Patel DD
    Cancer Lett; 1994 Jul; 82(2):129-33. PubMed ID: 8050082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sialic acid and carcinoembryonic antigen (CEA) as markers of colon cancer: Preliminary report].
    Dabrowska B; Krasnodebski IW; Tadeusiak W
    Pol Tyg Lek; 1991 Nov 11-25; 46(45-47):890-1. PubMed ID: 1669462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum sialic acid--an important cancer marker.
    Tewarson SL; Mittal VP; Singh M; Gupta GP
    Indian J Cancer; 1993 Sep; 30(3):125-31. PubMed ID: 8300142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of different serum tumor markers in gynecological malignancies.
    Paulick R; Caffier H; Horner G; Lang K; Filbry E
    Cancer Detect Prev; 1985; 8(1-2):115-20. PubMed ID: 4064031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of serum sialic acid and lactate dehydrogenase in diagnosis and treatment monitoring of cervical cancer patients.
    Patel PS; Rawal GN; Balar DB
    Gynecol Oncol; 1993 Sep; 50(3):294-9. PubMed ID: 8406190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total and lipid-bound serum sialic acid in children with malignancy or infections.
    Romppanen J; Petäjä J; Heikinheimo M; Mononen I
    Anticancer Res; 1998; 18(4B):2793-7. PubMed ID: 9713463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evaluation of four tumor markers in malignant and benign pleural effusions.
    Toumbis M; Chondros K; Ferderigos AS; Daganou M; Dema A; Dalamaga A; Kakari S; Stringou E
    Anticancer Res; 1992; 12(4):1267-70. PubMed ID: 1503419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of serum sialoglycoproteins in patients with lung cancer.
    Patel PS; Baxi BR; Balar DB
    Neoplasma; 1989; 36(1):53-9. PubMed ID: 2539569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum biomarkers facilitate the recognition of early- stage cancer and may guide the selection of surgical candidates: a study of carcinoembryonic antigen and tissue polypeptide antigen in patients with operable non-small cell lung cancer.
    Buccheri G; Ferrigno D
    J Thorac Cardiovasc Surg; 2001 Nov; 122(5):891-9. PubMed ID: 11689793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnostic value of biochemical tumor markers in brain tumors. Review of the literature and own experience with serum analysis of sialic acid (NANA), carcinoembryonic antigen (CEA) and neuron-specific enolase (NSE)].
    Flaschka G; Marth E; Desoye G; Freidl W; Walzl M
    Zentralbl Neurochir; 1990; 51(3):129-37. PubMed ID: 2092546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The function of the level of serum carcinoembryonic antigen on early recurrence of non-small cell lung cancer].
    Zhang ZF; Ma JQ; Sun N; Zhang L
    Zhonghua Wai Ke Za Zhi; 2004 Jul; 42(13):817-9. PubMed ID: 15363304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.